Status:
UNKNOWN
Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Epilepsy
Children, Only
Eligibility:
All Genders
5-18 years
Brief Summary
There is little epidemiological data in the literature on the therapeutic compliance of epileptic children. Yet it is a fundamental issue in the therapeutic education and balance of this pathology. To...
Eligibility Criteria
Inclusion
- • Child aged 5 to 17
- Child who has received complete information on the organization of the research and who has not objected to his participation and the exploitation of his data
- Holder (s) of the parental authority present (s) having received the complete information on the organization of the research and not being opposed to the participation and the exploitation of the data of his child
- Epileptic child
- Follow-up at the neuro pediatric department of CHRU Nancy
Exclusion
- epileptic encephalopathy
- Multiply handicapped child
Key Trial Info
Start Date :
November 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03753035
Start Date
November 29 2018
End Date
September 30 2019
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GIRARD
Nancy, Lorraine, France, 54520